Concord Biotech Ltd.

NSE: CONCORDBIO | BSE: 543960 | ISIN: INE338H01029 | Industry: Biotechnology
| Expensive Performer
1760.8000 23.10 (1.33%)
NSE Jul 07, 2025 15:31 PM
Volume: 284.4K
 

1760.80
1.33%
Concord Biotech Ltd - 543960 - Board Meeting Outcome for Outcome Of Board Meeting Held Today, …
BSE India
Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, we enclose herewith the Unaudited Standalone and Consolidated Financial Results of the Company for the Second quarter and half year ended September 30, 2024, along with the Limited Review Report with Unmodified Opinion issued by M/s. BSR & Co. LLP, the Statutory auditors.
More from Concord Biotech Ltd.
Recommended